EssilorLuxottica Unveils Groundbreaking Randomized Controlled Trial on Plano Lenses for Myopia Prevention at CIIE

On November 8, EssilorLuxottica Group participated in the 7th China International Import Expo (hereinafter referred to as "CIIE") with the theme of "Gathering New Strength, Ensuring Quality Eye Health." Together with experts, they released the latest clinical research on Essilor's Stellest technology for children who have not yet developed myopia. This marks the first randomized controlled trial using plano lenses for myopia prevention. Since its global debut at the CIIE in 2020, Essilor's Stellest myopia control lenses have helped countless children slow down the progression of myopia under the continuous influence of the spillover effect. As a new breakthrough in existing products, the plano Stellest lenses were showcased at this year’s CIIE, further enhancing the solutions for managing myopia among children and adolescents, shifting from "control" to "prevention."

Professor Chen Zhi from the Eye, Ear, Nose and Throat Hospital of Fudan University Shares Research Progress on Essilor Stellest Lenses

Essilor Stellest Participates in CIIE for the Fifth Consecutive Year, Accelerating Entry into the Chinese Market to Benefit More Consumers. Over the years, Essilor Stellest has also continuously collaborated with industry experts on clinical research of lenses, further exploring new approaches of "control and prevention" synergy and early intervention. At this year’s CIIE, Professor Zhi Chen from the Eye, Ear, Nose, and Throat Hospital of Fudan University was invited to release his team's latest clinical study based on this product—a randomized controlled trial on the use of plano lenses for myopia prevention. Professor Chen Zhi stated that for children with low hyperopia reserve, wearing Essilor Stellest plano lenses for more than 30 hours per week can slow down axial length growth, and the longer the wear time, the more significant the effect.

Essilor Stellest™ Non-Prescription Lenses

Based on a keen insight into the Chinese market, Essilor Stellest has adhered to product innovation and category education, bringing leading, safe, and effective myopia management solutions to Chinese consumers. In the future, the brand will continue to collaborate with relevant institutions and industry partners to strengthen myopia prevention research and eye health education in the Chinese market, providing comprehensive protection for children and adolescents' eye health from "control" to "prevention."